Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification

被引:20
作者
Fan, Xiaohong [1 ]
Zhang, Xueyan [1 ]
Wang, Huimin [1 ]
Jin, Bo [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China
关键词
Lung adenocarcinoma; Prognostic factor; Pathologic stage I disease; TNM staging; FORTHCOMING 7TH EDITION; INTERNATIONAL ASSOCIATION; HISTOLOGIC FEATURES; MALIGNANT-TUMORS; CANCER; PROPOSALS; REVISION; PROJECT; IMPACT;
D O I
10.1007/s13277-014-1781-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The incidence of lung adenocarcinoma has been increased significantly year by year. In this histologic type, complete surgical resection is commonly chosen as treatment method at the initial stages. However, the postoperative survival rate remains unsatisfactory even within the stage I. The purpose of this study is to investigate the factors related with prognosis in stage I lung adenocarcinoma after surgical resection. In this manuscript, a retrospective study was performed. Survival rates were calculated by the Kaplan-Meier method, and for multivariate analyses, Cox proportional hazards regression model was used. The results indicated that a total of 531 patients were included. Overall 5-year survival was 81.2 %. Age, sex, pathologic stage, T category, tumor size, differentiation, necrosis, visceral pleural invasion (VPI), lymphatic vessel or vascular invasion, and serum carcinoembryonic antigen (CEA) were significantly associated with 5-year overall survival of the patients with Kaplan-Meier analysis. Moreover, on multivariate analyses, seven variables were shown to be independent prognostic factors, including differentiation (hazard ratios (HR), 1.357), VPI (HR, 0.551), lymphatic vessel or vascular invasion (HR, 0.533), necrosis (HR, 1.671), age (HR, 1.519), pathological stage (HR, 4.477), and CEA (HR, 2.099). In conclusion, the most important prognostic factor is pathologic stage. Other adverse prognostic factors include differentiation, VPI, lymphatic vessel or vascular invasion, necrosis, age, and CEA.
引用
收藏
页码:5905 / 5910
页数:6
相关论文
共 19 条
[1]
Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: A review of national cancer institute of Canada clinical trials group trials [J].
Asmis, Timothy R. ;
Ding, Keyue ;
Seymour, Lesley ;
Shepherd, Frances A. ;
Leighl, Natasha B. ;
Winton, Tim L. ;
Whitehead, Marlo ;
Spaans, Johanna N. ;
Graham, Barbara C. ;
Goss, Glenwood D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) :54-59
[2]
Chamogeorgakis Themistokles, 2009, Interact Cardiovasc Thorac Surg, V8, P364, DOI 10.1510/icvts.2008.178947
[3]
The Significance of Visceral Pleural Surface Invasion in 321 Cases of Non-Small Cell Lung Cancers with Pleural Retraction [J].
Chang, Yih-Leong ;
Lin, Mong-Wei ;
Shih, Jin-Yuan ;
Wu, Chen-Tu ;
Lee, Yung-Chie .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) :3057-3064
[4]
The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer [J].
Chansky, Kari ;
Sculier, Jean-Paul ;
Crowley, John J. ;
Giroux, Dori ;
Van Meerbeeck, Jan ;
Goldstraw, Peter .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) :792-801
[5]
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma [J].
Ebright, MI ;
Zakowski, MF ;
Martin, J ;
Venkatraman, ES ;
Miller, VA ;
Bains, MS ;
Downey, RJ ;
Korst, RJ ;
Kris, MG ;
Rusch, VW .
ANNALS OF THORACIC SURGERY, 2002, 74 (05) :1640-1647
[6]
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J].
Goldstraw, Peter ;
Crowley, John ;
Chansky, Kari ;
Giroux, Dorothy J. ;
Groome, Patti A. ;
Rami-Porta, Ramon ;
Postmus, Pieter E. ;
Rusch, Valerie ;
Sobin, Leslie .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :706-714
[7]
New Staging System: How Does It Affect Our Practice? [J].
Goldstraw, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) :984-991
[8]
The IASLC lung cancer staging project:: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer [J].
Rami-Porta, Ramon ;
Ball, David ;
Crowley, John ;
Giroux, Dorothy J. ;
Jett, James ;
Travis, William D. ;
Tsuboi, Masahiro ;
Vallieres, Eric ;
Goldstraw, Peter .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (07) :593-602
[9]
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer [J].
Scagliotti, Giorgio Vittorio ;
Parikh, Purvish ;
von Pawel, Joachim ;
Biesma, Bonne ;
Vansteenkiste, Johan ;
Manegold, Christian ;
Serwatowski, Piotr ;
Gatzemeier, Ulrich ;
Digumarti, Raghunadharao ;
Zukin, Mauro ;
Lee, Jin S. ;
Mellemgaard, Anders ;
Park, Keunchil ;
Patil, Shehkar ;
Rolski, Janusz ;
Goksel, Tuncay ;
de Marinis, Filippo ;
Simms, Lorinda ;
Sugarman, Katherine P. ;
Gandara, David .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3543-3551
[10]
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition [J].
Sculier, Jean-Paul ;
Chansky, Kari ;
Crowley, John J. ;
Van Meerbeeck, Jan ;
Goldstraw, Peter .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) :457-466